These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34479501)

  • 1. COVID-19 epidemiological, sociological and anthropological investigation: study protocol for a multidisciplinary mixed methods research in Burkina Faso.
    Traoré IT; Ouedraogo S; Kania D; Kaboré FN; Konaté B; Médah R; Badolo H; de Rekeneire N; Kamga AM; Poda A; Diendere AE; Ouédraogo B; Ouédraogo E; Billa O; Tinto H; Dabakuyo-Yonli TS
    BMC Infect Dis; 2021 Sep; 21(1):896. PubMed ID: 34479501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13).
    Kaboré NF; Ouédraogo S; Mamguem AK; Traoré IT; Kania D; Badolo H; Sanou G; Koné A; Yara M; Kagoné T; Ouédraogo E; Konaté B; Médah R; de Rekeneire N; Poda A; Diendéré AE; Ouédraogo B; Billa O; Paradis G; Dabakuyo-Yonli TS; Tinto H
    BMC Infect Dis; 2023 Jun; 23(1):394. PubMed ID: 37308819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the impact of COVID-19 in people coinfected with HIV and/or tuberculosis in low-income countries: study protocol for mixed methods research in Burkina Faso.
    Ouattara CA; Poda AG; Méda ZC; Sawadogo Y; Kabore O; Birba E; Sourabié A; Zoungrana J; Traore IT; Sangaré I; Ymba A; Godreuil S; Ouedraogo AS
    BMC Infect Dis; 2023 Feb; 23(1):108. PubMed ID: 36814211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population-based, age-stratified sero-epidemiological investigation.
    Ouedraogo S; Traoré IT; Kania D; Kaboré NF; Mamguem Kamga A; Badolo H; Yara M; Sanou G; Koné A; Kagoné ST; Ouédraogo E; Konaté B; Médah R; de Rekeneire N; Poda A; Diendere AE; Ouédraogo B; Billa O; Paradis G; Tinto H; Dabakuyo-Yonli TS
    Influenza Other Respir Viruses; 2023 Nov; 17(11):e13216. PubMed ID: 38019697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical management and mortality among COVID-19 cases in sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case analysis.
    Skrip L; Derra K; Kaboré M; Noori N; Gansané A; Valéa I; Tinto H; Brice BW; Gordon MV; Hagedorn B; Hien H; Althouse BM; Wenger EA; Ouédraogo AL
    Int J Infect Dis; 2020 Dec; 101():194-200. PubMed ID: 32987177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High seroprevalence of SARS-CoV-2 in Burkina-Faso, Ghana and Madagascar in 2021: a population-based study.
    Struck NS; Lorenz E; Deschermeier C; Eibach D; Kettenbeil J; Loag W; Brieger SA; Ginsbach AM; Obirikorang C; Maiga-Ascofare O; Sarkodie YA; Boham EEA; Adu EA; Asare G; Amoako-Adusei A; Yawson A; Boakye AO; Deke J; Almoustapha NS; Adu-Amoah L; Duah IK; Ouedraogo TA; Boudo V; Rushton B; Ehmen C; Fusco D; Gunga L; Benke D; Höppner Y; Rasolojaona ZT; Rasamoelina T; Rakotoarivelo RA; Rakotozandrindrainy R; Coulibaly B; Sié A; Awuah AA; Amuasi JH; Souares A; May J
    BMC Public Health; 2022 Sep; 22(1):1676. PubMed ID: 36064368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Epidemiology of SARS-CoV-2 in Western Burkina Faso, West Africa.
    Sawadogo Y; Galal L; Belarbi E; Zongo A; Schubert G; Leendertz F; Kanteh A; Sesay AK; Erhart A; Bañuls AL; Tarnagda Z; Godreuil S; Tinto H; Ouedraogo AS
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of SARS-CoV-2 in urban settings in three sub-Saharan African countries (SeroCoV): a study protocol for a household-based cross-sectional prevalence study using two-stage cluster sampling.
    Lorenz E; Souares A; Amuasi J; Loag W; Deschermeier C; Fusco D; Benke D; A Rakotoarivelo R; Rasamoelina MT; Rakotozandrindrainy R; Sie A; Afum-Adjei Awuah A; May J; Eibach D; Struck N
    BMJ Open; 2021 Dec; 11(12):e056853. PubMed ID: 34921091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology of syphilis among men who have sex with men in Burkina Faso, West Africa.
    Ouedraogo HG; Zida S; Compaore TR; Lanou BH; Rao A; Sagna T; Kadari C; Tarnagda G; Ky-Zerbo O; Traore Y; Baral S; Kouanda S; Barro N
    Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1803-1809. PubMed ID: 31201641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of SARS-CoV-2 and co-infection with malaria during the first wave of the pandemic (the Burkina Faso case).
    López-Farfán D; Yerbanga RS; Parres-Mercader M; Torres-Puente M; Gómez-Navarro I; Sanou DMS; Yao AF; Bosco Ouédraogo J; Comas I; Irigoyen N; Gómez-Díaz E
    Front Public Health; 2022; 10():1048404. PubMed ID: 36579069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Adolescent Sexual and Reproductive Health Outcomes Before and Into the COVID-19 Pandemic in Burkina Faso and Kenya: Evidence From Panel Data.
    Silberg C; Moreau C; Karp C; Bazié F; Gichangi P; Guiella G; Onadja Y; Thiongo M; Anglewicz P
    J Adolesc Health; 2024 Aug; 75(2):344-352. PubMed ID: 38878048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible Impact of COVID-19 on Children in Africa, Reflections from Italy and Burkina Faso.
    Ouedraogo P; Schumacher RF
    J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 32766698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and Predictors of Imported Cases of COVID-19 in Burkina Faso.
    Kaboré M; Sondo KA; Dahourou DL; Cissoko Y; Konaté I; Zaré A; Bicaba B; Ouedraogo B; Barro H; Diendéré EA; Asamoah I; Damoue SN; Siri BAA; Diallo I; Puplampu P; Poda AG; Toloba Y; Dao S; Ouédraogo M; Kouanda S
    Front Public Health; 2022; 10():743248. PubMed ID: 35252079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
    Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
    Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of SARS-CoV-2 IgG and associated factors among people living with HIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso, a sub-Saharan African country.
    Kaboré OD; Poda A; Ouattara CA; Michodigni FN; Belem AA; Sawadogo Y; Zoungrana J; Galal L; Meda CZ; Godreuil S; Ouédraogo AS
    PLoS One; 2023; 18(6):e0286665. PubMed ID: 37315090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring Insecticide Susceptibility in
    Namountougou M; Soma DD; Balboné M; Kaboré DA; Kientega M; Hien A; Coulibaly A; Ouattara PE; Meda BG; Drabo S; Koala L; Nignan C; Kagoné T; Diabaté A; Fournet F; Gnankiné O; Dabiré RK
    Trop Med Infect Dis; 2020 May; 5(2):. PubMed ID: 32471266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of seasonal malaria chemoprevention with enhanced infection prevention and control measures during the COVID-19 pandemic in Nigeria, Burkina Faso and Chad: a cross-sectional study.
    Ward C; Phillips A; Oresanya O; Olisenekwu G; Arogunade E; Moukénet A; Beakgoubé H; De Paul Allambademel V; Compaoré CS; Traoré A; Ouedraogo JB; Compaoré YD; Zongo I; Donovan L; Decola MA; Smith H; Baker K
    Malar J; 2022 Mar; 21(1):103. PubMed ID: 35331248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination coverage in rural Burkina Faso under the effects of COVID-19: evidence from a panel study in eight districts.
    Cooper S; Bicaba F; Tiendrebeogo CO; Bila A; Bicaba A; Druetz T
    BMC Health Serv Res; 2023 Sep; 23(1):1016. PubMed ID: 37735414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.